norovirus and glp 1 The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review Norovirus Sickens Nearly 100 Aboard

Role of C-reactive protein at sites of inflammation and infection

Common side effects Nausea (the most common one across both) Constipation Diarrhoea Fatigue (in early weeks) Vomiting (Commonly during dose increases) Most are gastrointestinal, mild to moderate, and improve significantly after the dose escalation phase

33 Participants enrolled were receiving stable daily doses of one or two glucose-lowering drugs (metformin, sulfonylureas, SGLT-2 inhibitors, or thiazolidinediones)

The antioxidant function of GSH is determined by the redox-active thiol (-SH) of cysteine that becomes oxidized when GSH reduces target molecules (Pompella et al., 2003)

Individuals with kidney disease: Since the kidneys filter toxins from the blood, people with kidney problems may be at increased risk of problems

Thus, this modest increase in LDL-C may be misleading regarding ASCVD risk, as patients with obesity may have a higher concentration of atherogenic small, dense LDL particles, and therefore high levels of apoB for a given blood LDL-C [10, 13]